Sort
50,496 grants matching “lung cancer”
Optical Technologies for Cervical Neoplasia
$2,357,097University Of Texas Md Anderson Can Ctr · P01 · FY2004 · CA
Immunotoxin Therapy of Solid and Hematopoietic Tumors: Preclinical Studies
$2,356,009Ira Pastan · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Elucidating Cell Communication Networks during Tissue Inflammation, Fibrosis, and Regeneration
$2,355,000Kevin R King · University Of California, San Diego · DP2 · FY2018 · AR
SPORE in Lung Cancer
$2,353,640John D Minna · Ut Southwestern Medical Center · P50 · FY2007 · CA
(2 of 2) Genetic Epidemiology of COPD
$2,353,435Edwin K Silverman · Brigham And Women'S Hospital · U01 · FY2017 · HL
Point-of care Microfluidics for Early Detection of Cancer
$2,352,119Mehmet Toner · Massachusetts General Hospital · U01 · FY2012 · EB
SPORE in Lung Cancer
$2,349,769Mark A Socinski · University Of Pittsburgh At Pittsburgh · P50 · FY2013 · CA
Discovery of Chemical Probes and Therapeutic Leads, Phase II
$2,349,582Joseph M Fox · University Of Delaware · P20 · FY2020 · GM
Discovery of Rational Companion Therapeutic Targets to Optimize Cancer Treatment
$2,348,750Trever G Bivona · University Of California, San Francisco · DP2 · FY2012 · CA
The HMS Laboratory of Systems Pharmacology
$2,346,106Peter Karl Sorger · Harvard Medical School · P50 · FY2014 · GM
Lung Cancer Mutation Analysis
$2,345,250Paul A Bunn · University Of Colorado Denver · RC2 · FY2010 · CA
Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.
$2,344,269Christopher Hourigan · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL
Sparking Advancements in Genomic Medicine
$2,344,174Julie A. Johnson · University Of Florida · U01 · FY2019 · HG
Improving the Clinical Effectiveness and Understanding of the Biophysical Basis
$2,343,081Thomas F Delaney · Massachusetts General Hospital · U19 · FY2014 · CA
Cancer Center Support Grant
$2,342,475Robert Figlin · Beckman Research Institute/City Of Hope · P30 · FY2009 · CA
PLCO Trial Etiologic and Early Marker Study
$2,342,091Richard S Hayes · Division Of Cancer Epidemiology And Genetics · Z01 · FY2008 · CA
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
$2,341,652Roy S Herbst · Yale University · P50 · FY2025 · CA
Pharmaceutical Research Center
$2,340,738Karam F.a. Soliman · Florida Agricultural And Mechanical Univ · G12 · FY2012 · MD
Development of Akt Inhibitors
$2,338,621Phillip A. Dennis · Basic Sciences · Z01 · FY2007 · CA
Identification and regulation of signal transduction pathways that promote survi
$2,338,621Phillip A. Dennis · Clinical Sciences · Z01 · FY2007 · CA
Center for Cancer Immunology and Immunotherapy (CCII)
$2,337,631Jun Yan · University Of Louisville · P20 · FY2020 · GM
The Kansas Institute for Precision Medicine
$2,337,371Andrew K Godwin · University Of Kansas Medical Center · P20 · FY2024 · GM
Center for Cancer Nanotechnology Excellence and Translation (CCNE-T)
$2,334,507Sanjiv S Gambhir · Stanford University · U54 · FY2013 · CA
Integrative analysis of lung cancer etiology and risk
$2,334,007Christopher I. Amos · Baylor College Of Medicine · U19 · FY2021 · CA
Canadian Cancer Trials Group - Canadian Collaborating Clinical Trials Network
$2,333,866Janet Ellen Dancey · Queen'S University At Kingston · U10 · FY2024 · CA